$18.01
0.32% yesterday
Nasdaq, Jul 16, 10:00 pm CET
ISIN
US3596641098
Symbol
FLGT

Fulgent Genetics Stock price

$18.04
-2.90 13.85% 1M
+0.54 3.09% 6M
-0.43 2.33% YTD
-3.83 17.51% 1Y
-39.12 68.44% 3Y
-2.13 10.56% 5Y
+8.86 96.51% 10Y
+8.86 96.51% 20Y
Nasdaq, Closing price Wed, Jul 16 2025
-0.03 0.17%
ISIN
US3596641098
Symbol
FLGT
Sector

Key metrics

Basic
Market capitalization
$549.2m
Enterprise Value
$231.9m
Net debt
positive
Cash
$320.3m
Shares outstanding
30.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.9 | 1.7
EV/Sales
0.8 | 0.7
EV/FCF
negative
P/B
0.5
Financial Health
Equity Ratio
92.9%
Return on Equity
-3.8%
ROCE
-7.2%
ROIC
-8.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$292.5m | $316.9m
EBITDA
$-74.0m | $-19.9m
EBIT
$-82.0m | $-79.2m
Net Income
$-40.8m | $-17.2m
Free Cash Flow
$-31.6m
Growth (TTM | estimate)
Revenue
1.7% | 11.8%
EBITDA
59.9% | 69.8%
EBIT
57.4% | -7.1%
Net Income
75.4% | 59.8%
Free Cash Flow
-276.5%
Margin (TTM | estimate)
Gross
38.8%
EBITDA
-25.3% | -6.3%
EBIT
-28.0%
Net
-13.9% | -5.4%
Free Cash Flow
-10.8%
More
EPS
$-1.3
FCF per Share
$-1.0
Short interest
10.0%
Employees
1k
Rev per Employee
$220.0k
Show more

Is Fulgent Genetics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Fulgent Genetics Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Fulgent Genetics forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Fulgent Genetics forecast:

Buy
67%
Hold
33%

Financial data from Fulgent Genetics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
292 292
2% 2%
100%
- Direct Costs 179 179
0% 0%
61%
113 113
5% 5%
39%
- Selling and Administrative Expenses 128 128
1% 1%
44%
- Research and Development Expense 50 50
16% 16%
17%
-74 -74
60% 60%
-25%
- Depreciation and Amortization 7.97 7.97
0% 0%
3%
EBIT (Operating Income) EBIT -82 -82
57% 57%
-28%
Net Profit -41 -41
75% 75%
-14%

In millions USD.

Don't miss a Thing! We will send you all news about Fulgent Genetics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fulgent Genetics Stock News

Neutral
Business Wire
about 2 hours ago
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced it has received CE certification under the European Union (EU)'s In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) for its germline next-generation sequenc...
Neutral
Business Wire
7 days ago
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2025 financial results before the market opens on Friday, August 1, 2025. Management will host a conference call for t...
Neutral
GlobeNewsWire
about 2 months ago
NEWTOWN, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT), resulting from allegations of providing potentially misleading business information to the investing public.
More Fulgent Genetics News

Company Profile

Fulgent Genetics, Inc. operates as a technology company, which provides genetic testing and next generation sequencing solutions. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Head office United States
CEO Ming Hsieh
Employees 1,313
Founded 2016
Website www.fulgentgenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today